Signaling Pathways
-
A5354 ZonisamideTarget: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: Antiepileptic with anticonvulsant and mechanistic effect
-
A8513 RiluzoleTarget: Voltage-gated Sodium (NaV) Channels|glutamate releaseSummary: Sodium channel protein inhibitor
-
B2277 A-803467Target: Voltage-gated Sodium (NaV) ChannelsSummary: NaV1.8 channel blocker,potent and selective
-
A3418 Flecainide acetateTarget: Voltage-gated Sodium (NaV) ChannelsSummary: Antiarrhythmic drug
-
B2274 Proparacaine HClTarget: Voltage-gated Sodium (NaV) ChannelsSummary: voltage-gated sodium channels antagonist
-
B2272 Phenytoin sodiumTarget: Voltage-gated Sodium (NaV) ChannelsSummary: Sodium channel stabilizer
-
B1420 Bupivacaine HClTarget: Voltage-gated Sodium (NaV) ChannelsSummary: Anaesthetic drug
-
B2268 Amiloride HCl dihydrateTarget: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|UrokinasesSummary: potent epithelial sodium channel (ENaC) blocker
-
A8718 GX-674Target: Voltage-gated Sodium (NaV) ChannelsSummary: Nav1.7 antagonist
-
B7590 QuinidineTarget: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)Summary: reduces both Na+ and K+ channel currents